Comparison of ranitidine and cimetidine maintenance treatment of duodenal ulcer.
Walt Rp, Hunt Rh, Misiewicz Jj, I F Trotman, S Colley, Dewar Ep, Frost Ra, Shepherd Th, Golding Pl, Colin-Jones Dg
Abstract
Walt Rp, Hunt Rh, Misiewicz Jj, I F Trotman, S Colley, Dewar Ep, Frost Ra, Shepherd Th, Golding Pl, Colin-Jones Dg
Abstract
Sixty-one patients with healed duodenal ulcer were studied during a 12-month maintenance trial with either 150 mg ranitidine at night or 400 mg cimetidine at night. Recurrences were determined at endoscopy after 6 and 12 months of treatment or because of symptomatic relapse. Ulcers recurred in 7 of 28 patients receiving ranitidine and in 8 of 33 patients receiving cimetidine. No serious side effects were encountered.
OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Sixty-one patients with healed duodenal ulcer were studied during a 12-month maintenance trial with either 150 mg ranitidine at night or 400 mg cimetidine at night. Recurrences were determined at endoscopy after 6 and 12 months of treatment or because of symptomatic relapse. Ulcers recurred in 7 of 28 patients receiving ranitidine and in 8 of 33 patients receiving cimetidine. No serious side effects were encountered.
Key concepts: Cimetidine, Ranitidine, Medicine, Duodenal ulcer, Gastroenterology, Endoscopy, Maintenance therapy, Internal medicine